|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo显示文摘 | Chao Jiang Miao Mei Bin Li Xiurui Zhu Wenhong Zu Yujie Tian Qiannan Wang Yong GUO Yizhou Dong Xu Tan | 2017 | Cell Research2017，27，3： | 12 |
| 2 | Facile one-pot synthesis of NiCo2O4 hollow spheres with controllable number of shells for high-performance supercapacitors显示文摘在这个工作,轰炸单人赛并且双 shelled NiCo 2 O 4 空范围被木糖帮助的一个一个壶 solvothermal 方法在 situ 综合了,由热处理列在后面。作为 supercapacitor 电极材料采用了,双 shelled NiCo 2 空范围展出的 O 4 一个显著特定的电容(1,204.4 F 漠 ? 牰獯桴瑥捩朠潲灵吗? | Jing Guo Zhihui Yin Xiaoxian Zang Ziyang Dai, Yizhou Zhang Wei Huang Xiaochen Dong | 2017 | Nano Research2017，10，2： | 4 |
| 3 | Microstructure of Carbides at Grain Boundaries in Nickel Based Superalloys显示文摘It is well known that carbides at grain boundaries play an important role in affecting mechanical properties of nickel based superalloys. In order to deeply understand the relationship between grain boundary structures and properties, in this work, we have investigated the microstructure of grain boundaries with different misorientation angles in bicrystals of nickel based superalloys. It is found that the bicrystals with smaller misorientation angles contain denser M 23 C 6 but sparse MC particles at grain boundaries, and this kind of bicrystals presents longer stress rupture lives. It was observed that MC carbides were decorated by M 23 C 6 and M 6 C particles at grain boundaries. The formation of these carbide particles, therefore, is likely due to the local fluctuation of chemical composition around MC carbides. In addition, the orientation relationships between MC carbides and γ/γ matrix were also determined. | Xiaoming Dong Xiaoli Zhang Kui Du Yizhou Zhou Tao Jin Hengqiang Ye | 2012 | Journal of Materials Science & Technology2012，28，11： | 4 |
| 4 | Long-term storage of lipid-like nanoparticles for mRNA delivery显示文摘Lipid-like nanoparticles(LLNs)have been extensively explored for messenger RNA(mRNA)delivery in various biomedical applications.However,the long-term storage of these nanoparticles is still a challenge for their clinical translation.In this study,we investigated a series of conditions for the long-term storage of LLNs with encapsulation of mRNA.We evaluated the stability of LLNs with different concentrations of cryoprotectants(sucrose,trehalose or mannitol)under the conditions of freezing or lyophilization processes.Through in vitro and in vivo mRNA delivery studies,we identified the optimal storage condition,and found that the addition with 5%(w/v)sucrose or trehalose to LLNs could remain their mRNA delivery efficiency for at least three months in the liquid nitrogen storage condition. | Pengxuan Zhao Xucheng Hou Jingyue Yan Shi Du Yonger Xue Wenqing Li Guangya Xiang Yizhou Dong | 2020 | Bioactive Materials2020，5，2： | 3 |
| 5 | Graphene as an intermediary for enhancing the electron transfer rate: A free-standing Ni3S2@graphene@CogSs electrocatalytic electrode for oxygen evolution reaction显示文摘 | Qiuchun Dong Yizhou Zhang Ziyang Dai Peng Wang Min Zhao Jinjun Shao Wei Huang Xiaochen Dong | 2018 | Nano Research2018，11，3： | 3 |
| 6 | Heterojunction-Type Photocatalytic System Based on Inorganic Halide Perovskite CsPbBr3显示文摘of main observation and conclusion The heterojunction-type structure has shown significant merits in tuning the optical properties and carrier physics.Inspired by the excellent absorption capability of halide perovskite materials for visible light,a series of CsPbBr3/TiO2 heterojunction-type photocatalysts with various all-inorganic-perovskite/TiO2 ratios are successfully fabricated by the ligand-assisted reprecipitation(LARP)method.The heterojunction structure extends the light absorption of TiO2 with good chemical and structural stability.A Pb-O interaction at the CsPbBr3/TiO2 interface is observed by the XPS and confirmed by the TRPL showing improved interface carrier transport and stability.The heterojunction-type catalyst shows drastically enhanced photocatalytic activity towards the direct oxidation of toluene with 02 molecule,as an important reaction for organic chemical synthesis.The optimized sample shows an activity of 2356μmol·g^-1·h^-1 at 75℃,4 times of that of the naked CsPbBr3 nanocrystals,and 3 times of that of the bare TiO2.Based on the investigation with trapping agents,a reaction mechanism is hence proposed suggesting that the photo-generated hole may be involved in the rate-limiting step.This work demonstrates the potential of inorganic halide perovskite-based heterojunction structure for photocatalytic applications. | Enbo Zhu Yizhou Zhao Yi Dai Qiuhe Wang Yuanyuan Dong Qi Chen Yujing Li | 2020 | Chinese Journal of Chemistry2020，38，12： | 3 |
| 7 | Mesh editing with poisson-based gradient field manipulation显示文摘 | Yu Yizhou Zhon Kun Xu Dong | 2004 | ACM Transactions on Graphics2004，23，3： | 1 |
| 8 | Chemotherapy drugs derived nanoparticles encapsulating mRNA encoding tumor suppressor proteins to treat triple-negative breast cancer显示文摘Triple-negative breast cancer(TNBC)is one type of the most aggressive breast can cers with poor prog no sis.It is of great urgency to develop new therapeutics for treati ng TNBC.Based on curre nt treatment guideline and genetic informatio n of TNBC,a combi nation al therapy platform in tegrati ng chemotherapy drugs and mRNA encoding tumor suppressor proteins may become an efficacious strategy.In this study,we developed paclitaxel amino lipid(PAL)derived nanoparticles(NPs)to incorporate both chemotherapy drugs and P53 mRNA.The PAL P53 mRNA NPs showed superior properties compared to Abraxane? and Lipusu? used in the clinic including high paclitaxel loading capacity(24 wt.%,calculated by paclitaxel in PAL),PAL encapsulation efficiency(94.7%±6.8%)and mRNA encapsulation efficiency(88.7%±0.7%).Meanwhile,these NPs displayed synergetic cytotoxicity of paclitaxel and P53 mRNA in cultured TNBC cells.More importantly,we demonstrated in vivo anti-tumor efficacy of PAL P53 mRNA NPs in an orthotopic TNBC mouse model.Overall,these chemotherapy drugs derived mRNA NPs provide a new platform to integrate chemotherapy and personalized medicine using tumor genetic information,and therefore represent a promising approach for TNBC treatment. | Chengxiang Zhang Xinfu Zhang Weiyu Zhao Chunxi Zeng Wenqing Li Bin Li Xiao Luo Junan Li Justin Jiang Binbin Deng David W. McComb Yizhou Dong | 2019 | Nano Research2019，12，4： | 1 |
| 9 | Mesh editing with Poisson-based gradient field manipulation显示文摘 | Yu Yizhou Zhou Kun Xu Dong | 2004 | ACM Transactions on Graphics2004，23，3： | 1 |
| 10 | Mesh editing with poisson- based gradient field manipulation 显示文摘 | Yu Yizhou Zhou Kun Xu Dong | 2004 | ACM Transactions on Graphics2004，23，3： | 1 |
| 11 | Co-delivery of mRNA and SPIONs through amino-ester nanomaterials显示文摘 | Xiao Luo Weiyu Zhao Bin Li Xinfu Zhang Chengxiang Zhang Anna Bratas Binbin Deng David W. McComb Yizhou Dong | 2018 | Nano Research2018，11，10： | 1 |
| 12 | Potassium ion pre‑intercalated MnO_(2)for aqueous multivalent ion batteries显示文摘Manganese dioxide(MnO_(2)),as a cathode material for multivalent ion(such as Mg^(2+)and Al^(3+))storage,is investigated due to its high initial capacity.However,during multivalent ion insertion/extraction,the crystal structure of MnO_(2)partially collapses,leading to fast capacity decay in few charge/discharge cycles.Here,through pre-intercalating potassium-ion(K+)intoδ-MnO_(2),we synthesize a potassium ion pre-intercalated MnO_(2),K_(0.21)MnO_(2)·0.31H_(2)O(KMO),as a reliable cathode material for multivalent ion batteries.The as-prepared KMO exhibits a high reversible capacity of 185 mAh/g at 1 A/g,with considerable rate performance and improved cycling stability in 1 mol/L MgSO_(4)electrolyte.In addition,we observe that aluminum-ion(Al^(3+))can also insert into a KMO cathode.This work provides a valid method for modifcation of manganesebased oxides for aqueous multivalent ion batteries. | Zikang Xu Ruiqi Ren Hang Ren Jingyuan Zhang Jinyao Yang Jiawen Qiu Yizhou Zhang Guoyin Zhu Liang Huang Shengyang Dong | 2023 | Frontiers of Optoelectronics2023，16，4： | 0 |
| 13 | Roadmap for rechargeable batteries:present and beyond显示文摘Rechargeable batteries currently hold the largest share of the electrochemical energy storage market,and they play a major role in the sustainable energy transition and industrial decarbonization to respond to global climate change.Due to the increased popularity of consumer electronics and electric vehicles,lithium-ion batteries have quickly become the most successful rechargeable batteries in the past three decades,yet growing demands in diversified application scenarios call for new types of rechargeable batteries.Tremendous efforts are made to developing the next-generation post-Li-ion rechargeable batteries,which include,but are not limited to solid-state batteries,lithium–sulfur batteries,sodium-/potassium-ion batteries,organic batteries,magnesium-/zinc-ion batteries,aqueous batteries and flow batteries.Despite the great achievements,challenges persist in precise understandings about the electrochemical reaction and charge transfer process,and optimal design of key materials and interfaces in a battery.This roadmap tends to provide an overview about the current research progress,key challenges and future prospects of various types of rechargeable batteries.New computational methods for materials development,and characterization techniques will also be discussed as they play an important role in battery research. | Sen Xin Xu Zhang Lin Wang Haijun Yu Xin Chang Yu-Ming Zhao Qinghai Meng Pan Xu Chen-Zi Zhao Jiahang Chen Huichao Lu Xirui Kong Jiulin Wang Kai Chen Gang Huang Xinbo Zhang Yu Su Yao Xiao Shu-Lei Chou Shilin Zhang Zaiping Guo Aobing Du Guanglei Cui Gaojing Yang Qing Zhao Liubing Dong Dong Zhou Feiyu Kang Hu Hong Chunyi Zhi Zhizhang Yuan Xianfeng Li Yifei Mo Yizhou Zhu Dongfang Yu Xincheng Lei Jianxiong Zhao Jiayi Wang Dong Su Yu-Guo Guo Qiang Zhang Jun Chen Li-Jun Wan | 2024 | Science China Chemistry2024，67，1： | 0 |
| 14 | The novel SLC40A1(T419I)variant results in a loss-of-function phenotype and may provide insights into the mechanism of large granular lymphocytic leukemia and pure red cell aplasia显示文摘Variants in the solute carrier family 40 member 1(SLC40A1)gene are the molecular basis of ferroportin disease,which is an autosomal dominant hereditary hemochromatosis.Here,we present a patient with pure red cell aplasia(PRCA)and large granular lymphocytic leukemia(LGLL)associated with an extremely high levels of serum ferritin and iron overload syndrome.Whole exon sequencing revealed a novel heterozygous variant in SLC40A1(p.T419I),which was found in his daughter as well.A series of functional studies in vitro of the T419I variant in ferroportin were conducted and the results revealed a reduced capacity of iron export from cells without changes in protein localization and its sensitivity to hepcidin.Intracellular iron storage in mutated cells was significantly higher than that of wild-type.These findings suggest that the novel variant p.T419I can cause the classical form of ferroportin disease and an elevated intracellular iron level indicates a potential novel pathogenic mechanism underlying PRCA and LGLL. | Hongfei Wu Xiang Ren Meili Ge Peiyuan Dong Shichong Wang Huiming Yi Xingxin Li Jiali Huo Xuan Zheng Mengying Gao Jinbo Huang Jing Zhang Min Wang Peng Jin Neng Nie Yingqi Shao Yizhou Zheng | 2022 | Blood Science2022，4，1： | 0 |
| 15 | mRNA delivery in cancer immunotherapy显示文摘Messenger RNA(mRNA)has drawn much attention in the medical field.Through various treatment approaches including protein replacement therapies,gene editing,and cell engineering,mRNA is becoming a potential therapeutic strategy for cancers.However,delivery of mRNA into targeted organs and cells can be challenging due to the unstable nature of its naked form and the low cellular uptake.Therefore,in addition to mRNA modification,efforts have been devoted to developing nanoparticles for mRNA delivery.In this review,we introduce four categories of nanoparticle platform systems:lipid,polymer,lipid-polymer hybrid,and protein/peptide-mediated nanoparticles,together with their roles in facilitating mRNA-based cancer immunotherapies.We also highlight promising treatment regimens and their clinical translation. | Yichen Zhong Shi Du Yizhou Dong | 2023 | Acta Pharmaceutica Sinica B2023，13，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员